Literature DB >> 8718555

Induction of anti-tumor immunity by mouse tumor cells transfected with mouse interleukin-12 gene.

S Obana1, H Miyazawa, E Hara, T Tamura, H Nariuchi, M Takata, S Fujimoto, H Yamamoto.   

Abstract

Interleukin-12 (IL-12) is a heterodimeric cytokine. In order to transduce both cDNAs for p35 and p40 of IL-12 in the tumor cells, a polycistronic retroviral vector was constructed by inserting the internal ribosome entry site gene of encephalomyocarditis virus between two cDNAs. On the other hand, two cDNAs were sequentially transfected in the tumor cells. Both polycistronic gene transfectants and double transfectants produced biologically active mouse IL-12. IL-12-expressing tumor cells were all rejected in syngeneic mice, and induced cytotoxic T lymphocyte activity. The capacity to induce anti-tumor memory may depend on the amount of IL-12 produced by the transfectants, because the relatively higher IL-12 producer tumor cell line induced the anti-tumor memory in the rejected mice, but the lower producer did not.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8718555     DOI: 10.7883/yoken1952.48.221

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  3 in total

1.  Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

Authors:  Masanori Matsui; Osamu Moriya; Maria Laura Belladonna; Sadahiro Kamiya; François A Lemonnier; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12.

Authors:  D P Shrayer; B Cole; V J Hearing; S F Wolf; H J Wanebo
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 4.510

3.  Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.

Authors:  Anandaroop Mukhopadhyay; Jocelyn Wright; Shawna Shirley; David A Canton; Christoph Burkart; Richard J Connolly; Jean S Campbell; Robert H Pierce
Journal:  Gene Ther       Date:  2018-10-15       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.